None
No disclosed counterparties: XYL.
| Stage | XYL | % of rev | AP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $103M | 100.00% | XYL ×21.39 |
| Gross profit | $907M | 41.21% | $22M | 21.61% | XYL +19.6pp |
| Operating income | $385M | 17.49% | $5M | 4.93% | XYL +12.6pp |
| Pre-tax income | $365M | 16.58% | $3M | 2.75% | XYL +13.8pp |
| Net income | $288M | 13.08% | $2M | 2.09% | XYL +11.0pp |
| Stage | XYL | AP | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $103M100.00% | XYL ×21.39 |
| Gross profit | 41.21%$907M | 21.61%$22M | XYL +19.6pp |
| Operating income | 17.49%$385M | 4.93%$5M | XYL +12.6pp |
| Pre-tax income | 16.58%$365M | 2.75%$3M | XYL +13.8pp |
| Net income | 13.08%$288M | 2.09%$2M | XYL +11.0pp |